Investing Ideas
/
Italian Pharmaceuticals & Biotech Sustainable Track Record

Italian Pharmaceuticals & Biotech Sustainable Track Record

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

1 companies

Philogen

Market Cap: €938.6m

Philogen S.p.A., empresa de biotecnología, desarrolla medicamentos para oncología y enfermedades inflamatorias crónicas.

PHIL

€23.30

-9.3%

3.6%